Dr. Saro Khemichian, MD

Dr. Khemichian practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Khemichian's NPI, 1811920242, was assigned on July 9, 2006. Dr. Khemichian graduated from Keck School of Medicine of USC in 2003. Dr. Khemichian holds California license A90035.

Dr. Khemichian's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Khemichian's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Khemichian is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Khemichian to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khemichian practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Khemichian's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Khemichian is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Khemichian is licensed in California.

Dmand AI lists acute stomach ulcer, cirrhosis, cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding, gastrointestinal infection and hepatitis c among the conditions Dr. Khemichian treats.

CMS data shows 792 Medicare services from Dr. Khemichian across 7 procedure codes in 2024, for 316 Medicare patients. Medicare paid $56,713 for them.

CMS counts 316 Medicare patients who saw Dr. Khemichian in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 70% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khemichian's median patient age at 64, with 47% women.

In 2024, Dr. Khemichian wrote 1,369 Medicare Part D claims for 173 patients. 87% of them were for generic drugs. CMS names the drug for 1,137 of them, across 32 drugs with 11 or more claims each, at $352,602 in total drug cost. In 2023, CMS named 1,109 claims across 31 drugs.

Dr. Khemichian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khemichian as offering telehealth. CMS counts 18 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Khemichian, more than 48% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Khemichian, published from 2016 to 2020. Dr. Khemichian's most frequent co-authors are James Leonard Buxbaum, MD, Hyosun Han, MD and Linda Ann Hou, MD.

Dmand AI links Dr. Khemichian to 1 clinical trial. Open Payments lists research payments to Dr. Khemichian that name 1 trial.

CMS Open Payments shows 123 general payments to Dr. Khemichian from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Gilead Sciences, Inc. paid the most, $36,294. It also lists 21 research payments totaling $26,025 from 2018 to 2019, naming 1 clinical trial.

Dr. Khemichian graduated from Keck School of Medicine of USC in 2003. Dr. Khemichian is a member of ACG.

Dr. Khemichian is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.